3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Terminated
1
Suspended
1
Recruiting
1
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
35
Breast Neoplasms
30
Prostatic Neoplasms
22
Leukemia, Myeloid, Acute
20
Colorectal Neoplasms
20
Melanoma
17
Pancreatic Neoplasms
16
Glioblastoma
16
Carcinoma, Non-Small-Cell Lung
16
Neoplasm Metastasis
15
Lung Neoplasms
13
Brain Neoplasms
13
Glioma
12
Stomach Neoplasms
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Myelodysplastic Syndromes
11
Carcinoma, Hepatocellular
11
Ovarian Neoplasms
10
Multiple Myeloma
9
Head and Neck Neoplasms
9
Triple Negative Breast Neoplasms
8
Lymphoma
8
Carcinoma, Renal Cell
8
Leukemia
7
Sarcoma
6
Rectal Neoplasms
6
Hematologic Neoplasms
6
Esophageal Neoplasms
6
Uterine Cervical Neoplasms
5
Recurrence
5
Interventions
tocilizumab
1
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Methylprednisolone
1
Lopinavir
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Interventional
×
Respiratory Distress Syndrome
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled